BIONTECH
Dead / Cancelled — Cancelled — Section 8 (as of 27 Apr 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85085419
- Registration number
- 4027807
- Mark type
- Stylized text
- Filed
- 15 Jul 2010
- Published for opposition
- 05 Jul 2011
- Registered
- 20 Sept 2011
- Attorney of record
- Kathleen T. Petrich
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes
- Class 042 — Scientific and technological services: Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
Owner
- BioNTech AG, Mainz, DE
- BioNTech AG, Mainz, DE
- BioNTech AG, Mainz, DE
Prosecution history
- 27 Apr 2018 — CANCELLED SEC. 8 (6-YR)
- 20 Sept 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jan 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2014 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2014 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Nov 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Sept 2011 — REGISTERED-PRINCIPAL REGISTER
- 05 Jul 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jul 2011 — PUBLISHED FOR OPPOSITION
- 31 May 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 26 May 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 May 2011 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 11 May 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 May 2011 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 May 2011 — CORRESPONDENCE RECEIVED IN LAW OFFICE